• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Blogs » The Carlat Psychiatry Blog » How to Safely Prescribe Z-Drugs

The Carlat Psychiatry Blog
The Carlat Psychiatry Blog RSS FeedRSS

How to Safely Prescribe Z-Drugs

August 13, 2020
There’s good reason to be careful prescribing Z-drugs. Here’s an overview of Dr. Reban Aziz’s recent article in The Carlat Addiction Treatment Report.

Safety Tips

  1. Go short-term or intermittent to reduce the potential for adverse events and withdrawal.

  2. Avoid for SUD or complex sleep disorders. 

  3. Use as last resort after considering other meds and non-medication therapies.

  4. Educate patients to prevent driving impairment, complex sleep behaviors, and overdose. 


Potential Dangers

  • Adverse drug events. Including falls, head injuries, sedation, and vertigo. Zolpidem can also increase the likelihood of fractures resulting from falls in elderly patients (Kang DY et al, J Prev Med Public Health 2012;45(4):219–226). Zolpidem was implicated in 12% of all ED visits and, in such visits, 21% of the involved individuals were 65 years or older (Hampton LM et al, JAMA Psychiatry 2014;71(9):1006–1014).

  • Dangerous complex sleep behaviors. Including overdosing, falling, getting burned, shooting themselves, and wandering outside in cold weather. From 1992 to 2019, voluntarily reported cases to the FDA indicated that Z-drugs were attributed to 66 serious cases of complex sleep behaviors, 20 of which resulted in death. (www.fda.gov/consumers/consumer-updates/taking-z-drugs-insomnia-know-risks).

  • Motor vehicle accidents. A zolpidem blood level of 50 ng/mL can increase the risk of motor vehicle accidents by inhibiting a person's driving ability. The FDA determined that a higher percentage of individuals experience morning impairment after using extended-release zolpidem than that of patients who use short-acting zolpidem (www.fda.gov/media/84992/download). 

  • Withdrawal. Prolonged usage of zolpidem is directly associated with an increased probability of withdrawal. Zolpidem is the top withdrawal offender, but all Z-drugs, including zopiclone and eszopiclone, can induce withdrawal symptoms. (Schifano F et al, Int J Neuropsychopharmacol 2019;22(4):270–277).

  • Risk of an opioid overdose. Patients who are exposed to opioids, benzodiazepines, and non-benzodiazepine sedative-hypnotics at any point are 60% more likely to overdose than patients who are only exposed to opioids. 


Want to learn more? Click here for the full article from Dr. Aziz. Not a subscriber? Join here.
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2622607431.jpg
    General Psychiatry

    Should You Test MTHFR?

    MTHFR is a...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.